LINC02704

Across TCGA pan-cancer cohorts, LINC02704 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02704’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02704 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02704 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, HNSC, and THCA are the cancer types where LINC02704 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02704 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	−0.308	<.001	9	view →
HNSC	All	All	+0.334	.006	5	view →
THCA	Male	II,III,IV	+0.120	.018	3	view →
LUSC	All	III,IV	−0.444	.019	2	view →
KIRP	All	All	−0.026	.029	2	view →
PRAD	All	All	−0.017	.031	2	view →
KICH	All	All	−0.024	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02704–LUAD

Open the LUAD breakdown →